sitagliptin phosphate + Comparator: Placebo + Comparator: Sitagliptin
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Non-Insulin-Dependent
Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Trial Timeline
Jul 3, 2005 → Feb 13, 2006
NCT ID
NCT00758069About sitagliptin phosphate + Comparator: Placebo + Comparator: Sitagliptin
sitagliptin phosphate + Comparator: Placebo + Comparator: Sitagliptin is a phase 2 stage product being developed by Merck for Diabetes Mellitus, Non-Insulin-Dependent. The current trial status is completed. This product is registered under clinical trial identifier NCT00758069. Target conditions include Diabetes Mellitus, Non-Insulin-Dependent.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Non-Insulin-Dependent were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00758069 | Phase 2 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Non-Insulin-Dependent